The objective of the Biostatistics and Research Informatics Shared Resource (BRISR) is to provide collaborative and consultative services to Stanford Cancer Institute investigators and thereby add value in all phases of cancer research. Capabilities include high-quality biostatistics consultation on the use of standard methods, as well as innovation in statistical methods specifically developed to enhance the basic and translational research efforts of a discovery-oriented SCI. The BRISR operates under the direction of Drs. Phil Lavori, Tze Lai and Ying Lu. As a dedicated shared resource, BRISR benefits SCI investigators in need of statistical and analytic collaboration and consultation in their studies. Since 2009 the shared resource has served more than 130 SCI members representing all eight research programs. Significant methodological contributions by faculty and staff in this funding period include the introduction of new methods in high dimensional data analysis and genetic association studies, software tools for distributed computation (to avoid the need to aggregate data), as well as innovative designs for clinical trials, including Point-of-Care randomization methods, seamless Phase I/II designs, novel Phase I Bayesian designs, designs for biomarker-guided therapies, adaptive choice of subgroup, seamless Phase II/III designs and sequential randomization. The Shared Resource has the additional responsibility for expanding and managing the Stanford Cancer Institute Research Database (SCIRDB). This database allows SCI researchers to collect, integrate, and analyze de-identified patient data from the electronic health record (EPIC) and from a wide range of other data sources and provides consultative services to ensure its optimal use. Shared Resource staff also advise on strategic issues with statistical and informatics content, such as criteria for scientific review and development of databases and registries, as well as the re-engineering of clinical and research informatics across Stanford Medicine and its affiliated networks.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA124435-11
Application #
9491732
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2018-06-01
Budget End
2019-05-31
Support Year
11
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Stanford University
Department
Type
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94304
Patel, Manali I; Sundaram, Vandana; Desai, Manisha et al. (2018) Effect of a Lay Health Worker Intervention on Goals-of-Care Documentation and on Health Care Use, Costs, and Satisfaction Among Patients With Cancer: A Randomized Clinical Trial. JAMA Oncol 4:1359-1366
Trieu, Vanessa; Pinto, Harlan; Riess, Jonathan W et al. (2018) Weekly Docetaxel, Cisplatin, and Cetuximab in Palliative Treatment of Patients with Squamous Cell Carcinoma of the Head and Neck. Oncologist 23:764-e86
Kuonen, François; Surbeck, Isabelle; Sarin, Kavita Y et al. (2018) TGF?, Fibronectin and Integrin ?5?1 Promote Invasion in Basal Cell Carcinoma. J Invest Dermatol 138:2432-2442
Gee, Marvin H; Han, Arnold; Lofgren, Shane M et al. (2018) Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating Lymphocytes. Cell 172:549-563.e16
Malta, Tathiane M; Sokolov, Artem; Gentles, Andrew J et al. (2018) Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation. Cell 173:338-354.e15
Banerjee, Imon; Gensheimer, Michael Francis; Wood, Douglas J et al. (2018) Probabilistic Prognostic Estimates of Survival in Metastatic Cancer Patients (PPES-Met) Utilizing Free-Text Clinical Narratives. Sci Rep 8:10037
Thorsson, Vésteinn; Gibbs, David L; Brown, Scott D et al. (2018) The Immune Landscape of Cancer. Immunity 48:812-830.e14
Rogers, Zoë N; McFarland, Christopher D; Winters, Ian P et al. (2018) Mapping the in vivo fitness landscape of lung adenocarcinoma tumor suppression in mice. Nat Genet 50:483-486
Nair, Viswam S; Sundaram, Vandana; Desai, Manisha et al. (2018) Accuracy of Models to Identify Lung Nodule Cancer Risk in the National Lung Screening Trial. Am J Respir Crit Care Med 197:1220-1223
She, Richard; Jarosz, Daniel F (2018) Mapping Causal Variants with Single-Nucleotide Resolution Reveals Biochemical Drivers of Phenotypic Change. Cell 172:478-490.e15

Showing the most recent 10 out of 322 publications